Study to Evaluate the Efficacy and Safety of EP-104IAR in Patients With Osteoarthritis of the Knee
Trial details
- Registry ID
- NCT04120402
- Drugs studied
- EP-104IAR 25 mg, Vehicle
TrialRedline tracks 2 clinical trials sponsored by Eupraxia Pharmaceuticals Inc.: 1 Phase 2, 1 Phase 1 / 2.
Company identity checked against sources
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| Study to Evaluate the Efficacy and Safety of EP-104IAR in Patients With Osteoarthritis of the KneeNCT04120402 | EP-104IAR 25 mg, Vehicle | Completed | 2023-05-17Actual |
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| A Trial to Evaluate EP-104GI in Adults With Eosinophilic Esophagitis (EoE).NCT05608681 | EP-104GI | Recruiting | 2026-12Estimated |
Names as written in the registry records.